Cargando…
In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
Cryptococcal meningitis (CM), caused primarily by Cryptococcus neoformans, is uniformly fatal if not treated. Treatment options are limited, especially in resource-poor geographical regions, and mortality rates remain high despite current therapies. Here we evaluated the in vitro and in vivo activit...
Autores principales: | Shaw, Karen Joy, Schell, Wiley A., Covel, Jonathan, Duboc, Gisele, Giamberardino, C., Kapoor, Mili, Moloney, Molly, Soltow, Quinlyn A., Tenor, Jennifer L., Toffaletti, Dena L., Trzoss, Michael, Webb, Peter, Perfect, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105804/ https://www.ncbi.nlm.nih.gov/pubmed/29891599 http://dx.doi.org/10.1128/AAC.00523-18 |
Ejemplares similares
-
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia
por: Viriyakosol, Suganya, et al.
Publicado: (2019) -
Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species
por: Kapoor, Mili, et al.
Publicado: (2019) -
168. Efficacy of the Novel gwt1 Inhibitor APX2039 in a Rabbit Model of cryptococcus Meningitis
por: Shaw, Karen J, et al.
Publicado: (2020) -
Efficacy of Oral APX001 in a Murine Model of Cryptococcal Meningitis
por: Schell, Wiley A, et al.
Publicado: (2017) -
Fungal Cytological Profiling of Candida albicans Exposed to Diverse Antifungal Agents Including the Novel Gwt1 inhibitor APX001A
por: Sharp, Marc, et al.
Publicado: (2017)